ID   SPB11_HUMAN             Reviewed;         392 AA.
AC   Q96P15; A8K9R0; Q5Q120; Q5Q121; Q5Q122; Q5Q123; Q6ISD3; Q96P13; Q96P14;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-JUN-2023, entry version 144.
DE   RecName: Full=Serpin B11;
GN   Name=SERPINB11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND VARIANTS
RP   GLU-51; THR-148; ALA-181; THR-181; TRP-188; THR-293 AND SER-303.
RX   PubMed=17562709; DOI=10.1074/jbc.m703182200;
RA   Askew D.J., Cataltepe S., Kumar V., Edwards C., Pace S.M., Howarth R.N.,
RA   Pak S.C., Askew Y.S., Bromme D., Luke C.J., Whisstock J.C., Silverman G.A.;
RT   "SERPINB11 is a new noninhibitory intracellular serpin. Common single
RT   nucleotide polymorphisms in the scaffold impair conformational change.";
RL   J. Biol. Chem. 282:24948-24960(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-181.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-51.
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-181.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Has no serine protease inhibitory activity, probably due to
CC       mutations in the scaffold impairing conformational change.
CC       {ECO:0000269|PubMed:17562709}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=SERPINB11a;
CC         IsoId=Q96P15-1; Sequence=Displayed;
CC       Name=2; Synonyms=SERPINB11e;
CC         IsoId=Q96P15-2; Sequence=VSP_040671;
CC       Name=3; Synonyms=SERPINB11g;
CC         IsoId=Q96P15-3; Sequence=VSP_040670;
CC   -!- TISSUE SPECIFICITY: Detected in a restricted number of tissues,
CC       including lung, placenta, prostate, and tonsil.
CC       {ECO:0000269|PubMed:17562709}.
CC   -!- POLYMORPHISM: According to some authors, 4 of the identified SERPIN11
CC       transcripts contained coding sequences that could be distinguished by
CC       different combinations of single nucleotide polymorphisms (designated
CC       SERPINB11a, SERPINB11b, SERPINB11c, and SERPINB11d), and one contained
CC       a nonsense mutation introducing a premature stop codon in position 90
CC       identified in the official genome sequence (SERPINB11f)
CC       (PubMed:17562709). The sequence displayed here corresponds to
CC       SERPINB11a. {ECO:0000269|PubMed:17562709}.
CC   -!- SIMILARITY: Belongs to the serpin family. Ov-serpin subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Mutations in the scaffold leading to either a stop codon
CC       instead of a Glu at position 90, an Arg instead of the well conserved
CC       Trp at position 188, or a Pro instead of Ser at position 303 lead to
CC       the loss of inhibitory activity. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF419953; AAL16056.1; -; mRNA.
DR   EMBL; AF419954; AAL16057.1; -; mRNA.
DR   EMBL; AF419955; AAL16058.1; -; mRNA.
DR   EMBL; AY792323; AAV73920.1; -; mRNA.
DR   EMBL; AY792324; AAV73921.1; -; mRNA.
DR   EMBL; AY792325; AAV73922.1; -; mRNA.
DR   EMBL; AY792326; AAV73923.1; -; mRNA.
DR   EMBL; AK292775; BAF85464.1; -; mRNA.
DR   EMBL; AC069356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069596; AAH69596.1; -; mRNA.
DR   CCDS; CCDS77196.1; -. [Q96P15-2]
DR   RefSeq; NP_001278207.1; NM_001291278.1.
DR   RefSeq; NP_536723.2; NM_080475.3.
DR   AlphaFoldDB; Q96P15; -.
DR   SMR; Q96P15; -.
DR   BioGRID; 124598; 10.
DR   STRING; 9606.ENSP00000441497; -.
DR   MEROPS; I04.956; -.
DR   iPTMnet; Q96P15; -.
DR   PhosphoSitePlus; Q96P15; -.
DR   BioMuta; SERPINB11; -.
DR   DMDM; 20140144; -.
DR   EPD; Q96P15; -.
DR   MassIVE; Q96P15; -.
DR   PeptideAtlas; Q96P15; -.
DR   ProteomicsDB; 77594; -. [Q96P15-1]
DR   Antibodypedia; 23130; 147 antibodies from 20 providers.
DR   DNASU; 89778; -.
DR   Ensembl; ENST00000382749.9; ENSP00000421854.1; ENSG00000206072.13.
DR   GeneID; 89778; -.
DR   KEGG; hsa:89778; -.
DR   UCSC; uc032hfq.2; human. [Q96P15-1]
DR   AGR; HGNC:14221; -.
DR   CTD; 89778; -.
DR   DisGeNET; 89778; -.
DR   GeneCards; SERPINB11; -.
DR   HGNC; HGNC:14221; SERPINB11.
DR   HPA; ENSG00000206072; Tissue enhanced (esophagus, prostate).
DR   MIM; 615682; gene.
DR   neXtProt; NX_Q96P15; -.
DR   PharmGKB; PA37860; -.
DR   VEuPathDB; HostDB:ENSG00000206072; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   InParanoid; Q96P15; -.
DR   OrthoDB; 3218836at2759; -.
DR   PhylomeDB; Q96P15; -.
DR   PathwayCommons; Q96P15; -.
DR   BioGRID-ORCS; 89778; 3 hits in 241 CRISPR screens.
DR   ChiTaRS; SERPINB11; human.
DR   GenomeRNAi; 89778; -.
DR   Pharos; Q96P15; Tbio.
DR   PRO; PR:Q96P15; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q96P15; protein.
DR   Bgee; ENSG00000206072; Expressed in olfactory segment of nasal mucosa and 78 other tissues.
DR   ExpressionAtlas; Q96P15; baseline and differential.
DR   Genevisible; Q96P15; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IBA:GO_Central.
DR   CDD; cd19570; serpinB11_epipin; 1.
DR   Gene3D; 2.30.39.10; Alpha-1-antitrypsin, domain 1; 1.
DR   Gene3D; 3.30.497.10; Antithrombin, subunit I, domain 2; 1.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR036186; Serpin_sf.
DR   InterPro; IPR042178; Serpin_sf_1.
DR   InterPro; IPR042185; Serpin_sf_2.
DR   PANTHER; PTHR11461; SERINE PROTEASE INHIBITOR, SERPIN; 1.
DR   PANTHER; PTHR11461:SF199; SERPIN B11; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Serpins; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cytoplasm; Protease inhibitor; Reference proteome;
KW   Serine protease inhibitor.
FT   CHAIN           1..392
FT                   /note="Serpin B11"
FT                   /id="PRO_0000094117"
FT   REGION          341..365
FT                   /note="RCL"
FT                   /evidence="ECO:0000250"
FT   SITE            357..358
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         57..258
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040670"
FT   VAR_SEQ         120..206
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040671"
FT   VARIANT         51
FT                   /note="A -> E (in dbSNP:rs1395268)"
FT                   /evidence="ECO:0000269|PubMed:16177791,
FT                   ECO:0000269|PubMed:17562709"
FT                   /id="VAR_060331"
FT   VARIANT         148
FT                   /note="M -> T (in allele B and allele D; dbSNP:rs17071550)"
FT                   /evidence="ECO:0000269|PubMed:17562709"
FT                   /id="VAR_012472"
FT   VARIANT         181
FT                   /note="I -> A (in allele D; requires 2 nucleotide
FT                   substitutions)"
FT                   /evidence="ECO:0000269|PubMed:17562709"
FT                   /id="VAR_064572"
FT   VARIANT         181
FT                   /note="I -> T (in allele B and allele C)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17562709"
FT                   /id="VAR_012473"
FT   VARIANT         188
FT                   /note="R -> W (in allele D; dbSNP:rs1506419)"
FT                   /evidence="ECO:0000269|PubMed:17562709"
FT                   /id="VAR_060332"
FT   VARIANT         293
FT                   /note="I -> T (in dbSNP:rs1395266)"
FT                   /evidence="ECO:0000269|PubMed:17562709"
FT                   /id="VAR_060333"
FT   VARIANT         303
FT                   /note="P -> S (in dbSNP:rs1395267)"
FT                   /evidence="ECO:0000269|PubMed:17562709"
FT                   /id="VAR_060334"
FT   VARIANT         354
FT                   /note="I -> T (in dbSNP:rs34811964)"
FT                   /id="VAR_057177"
FT   CONFLICT        12
FT                   /note="C -> R (in Ref. 1; AAV73921)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43
FT                   /note="L -> P (in Ref. 1; AAV73923)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        91
FT                   /note="F -> S (in Ref. 1; AAV73920)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        267
FT                   /note="T -> A (in Ref. 1; AAV73920)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        356
FT                   /note="V -> A (in Ref. 1; AAV73921)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   392 AA;  44099 MW;  906F6DD412BCD756 CRC64;
     MGSLSTANVE FCLDVFKELN SNNIGDNIFF SSLSLLYALS MVLLGARGET AEQLEKVLHF
     SHTVDSLKPG FKDSPKCSQA GRIHSEFGVE FSQINQPDSN CTLSIANRLY GTKTMAFHQQ
     YLSCSEKWYQ ARLQTVDFEQ STEETRKMIN AWVENKTNGK VANLFGKSTI DPSSVMVLVN
     IIYFKGQRQN KFQVRETVKS PFQLSEGKNV TVEMMYQIGT FKLAFVKEPQ MQVLELPYVN
     NKLSMIILLP VGIANLKQIE KQLNSGTFHE WTSSSNMMER EVEVHLPRFK LEIKYELNSL
     LKPLGVTDLF NQVKADLSGM SPTKGLYLSK AIHKSYLDVS EEGTEAAAAT GDSIAVKSLP
     MRAQFKANHP FLFFIRHTHT NTILFCGKLA SP
//
